Witold Jamróz

Dr. Witold Jamróz

Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2018 in Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
Witold JamrózWitold Jamróz
Witold Jamróz
Joanna Szafraniec-SzczęsnyJoanna Szafraniec-Szczęsny
Joanna Szafraniec-Szczęsny
Mateusz KurekMateusz Kurek
Mateusz Kurek
RJRenata Jachowicz
Renata Jachowicz
Growing demand for customized pharmaceutics and medical devices makes the impact of additive manufacturing increased rapidly in recent years. The 3D printing has become one of the most revolutionary and powerful tool serving as a technology of precise manufacturing of individually developed dosage forms, tissue engineering and disease modeling. The current achievements include multifunctional drug delivery systems with accelerated release characteristic, adjustable and personalized dosage forms, implants and phantoms corresponding to specific patient anatomy as well as cell-based materials for regenerative medicine. This review summarizes the newest achievements and challenges of additive manufacturing in the field of pharmaceutical and biomedical research that have been published since 2015. Currently developed techniques of 3D printing are briefly described while comprehensive analysis of extrusion-based methods as the most intensively investigated is provided. The issue of printlets attributes, i.e. shape and size is described with regard to personalized dosage forms and medical devices manufacturing. The undeniable benefits of 3D printing are highlighted, however a critical view resulting from the limitations and challenges of the additive manufacturing is also included. The regulatory issue is pointed as well.

1 November 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Witold JamrózWitold Jamróz
Witold Jamróz
Mateusz KurekMateusz Kurek
Mateusz Kurek
EŁEwelina Łyszczarz
Ewelina Łyszczarz
Joanna Szafraniec-SzczęsnyJoanna Szafraniec-Szczęsny
Joanna Szafraniec-Szczęsny
Justyna Knapik-KowalczukJustyna Knapik-Kowalczuk
Justyna Knapik-Kowalczuk
RJRenata Jachowicz
Renata Jachowicz

1 October 2018 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Witold JamrózWitold Jamróz
Witold Jamróz
Mateusz KurekMateusz Kurek
Mateusz Kurek
ACAnna Czech
Anna Czech
Joanna Szafraniec-SzczęsnyJoanna Szafraniec-Szczęsny
Joanna Szafraniec-Szczęsny
KGKarolina Gawlak
Karolina Gawlak
RJRenata Jachowicz
Renata Jachowicz

7 March 2017 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
JSJustyna Szczurek
Justyna Szczurek
MRMarzena Rams-Baron
Marzena Rams-Baron
Justyna Knapik-KowalczukJustyna Knapik-Kowalczuk
Justyna Knapik-Kowalczuk
AAAgata Antosik-Rogóż
Agata Antosik-Rogóż
Joanna Szafraniec-SzczęsnyJoanna Szafraniec-Szczęsny
Joanna Szafraniec-Szczęsny
MPMarian Paluch
Marian Paluch

1 January 2018
Verified
Book
Closed access
MRMarzena Rams-Baron
Marzena Rams-Baron
RJRenata Jachowicz
Renata Jachowicz
EBElena Boldyreva
Elena Boldyreva
DZDeliang Zhou
Deliang Zhou
Witold JamrózWitold Jamróz
Witold Jamróz
MPMarian Paluch
Marian Paluch

1 February 2020 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Witold JamrózWitold Jamróz
Witold Jamróz
MKMateusz Kurek
Mateusz Kurek
Joanna Szafraniec-SzczęsnyJoanna Szafraniec-Szczęsny
Joanna Szafraniec-Szczęsny
ACAnna Czech
Anna Czech
KGKarolina Gawlak
Karolina Gawlak
RJRenata Jachowicz
Renata Jachowicz